Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Ceftazidime

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 369Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    04/06/2025 Nectar Lifesciences
    India
    		 M/sNectar Lifesciences Limted WC-0145 Ceftazidime for Injection USP/BP/Ph. Eur. 2022-11-18 2025-08-06 Unit-ll, Village-Saidpura, Tehsil-Derabassi, District-Sahibzada Ajit Singh Nagar, Punjab
    04/06/2025 Orchid Pharma
    India
    		 M/s Orchid Pharma Limited WC-0131 Ceftazidime (Sterile) IH 2022-06-28 2025-07-21 Plot No.121-128, 128A-133, 138-151 & 159-164, SIDCO Industrial Estate Alathur, Chengalpattu-603110, Tamil Nadu India